Safety profile of triple ICS/LABA/LAMA FDC in the treatment of asthma: a meta-analysis
L. Calzetta (Parma, Italy), F. Cavalli (Rome, Italy), A. Chetta (Parma, Italy), M. Cazzola (Rome, Italy), P. Rogliani (Rome, Italy)
Source: International Congress 2022 – Chronic airway diseases and infections: management and prevalence
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Calzetta (Parma, Italy), F. Cavalli (Rome, Italy), A. Chetta (Parma, Italy), M. Cazzola (Rome, Italy), P. Rogliani (Rome, Italy). Safety profile of triple ICS/LABA/LAMA FDC in the treatment of asthma: a meta-analysis. 2410
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|